Andover, MA, United States of America

Bolin Geng

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 6.9

ph-index = 4

Forward Citations = 35(Granted Patents)


Location History:

  • Waltham, MA (US) (2011 - 2016)
  • Andover, MA (US) (2017 - 2024)

Company Filing History:


Years Active: 2011-2024

Loading Chart...
Loading Chart...
10 patents (USPTO):

Title: Innovator Spotlight: Bolin Geng - Pioneering Advances in Biomedical Science

Introduction:

Bolin Geng, a distinguished inventor based in Andover, MA, has made remarkable contributions to the field of biomedical science. With an impressive portfolio of 10 patents, Geng has been at the forefront of developing cutting-edge compounds and methodologies aimed at enhancing proteasome activity and inhibiting cancer-related proteins like ATR.

Latest Patents:

Geng’s latest patents showcase his innovative approach to addressing crucial issues in the realm of proteostasis and cancer treatment. His groundbreaking work includes the development of proteasome activity enhancing compounds, as well as compounds designed to inhibit the ataxia telangiectasia and RAD3-related protein (ATR). These inventions hold immense promise for the treatment of conditions associated with disruptions in proteostasis and cancer.

Career Highlights:

Throughout his career, Bolin Geng has been associated with renowned companies such as AstraZeneca AB and Proteostasis Therapeutics, Inc. His tenure at these organizations has been marked by a relentless pursuit of scientific excellence and a commitment to pushing the boundaries of biomedical innovation. Geng's patents reflect his deep understanding of complex biological processes and his ability to translate that knowledge into tangible solutions.

Collaborations:

Geng’s collaborative spirit is evident in his work with talented professionals such as Matthew Cullen and Megan Foley. Together, they have explored novel avenues in drug discovery and development, pooling their expertise to drive meaningful advancements in the field of biomedicine. Geng's collaborations have been instrumental in shaping his innovative approach to research and invention.

Conclusion:

In conclusion, Bolin Geng stands as a visionary inventor whose pioneering work has the potential to revolutionize the treatment of proteostasis-related conditions and cancer. His dedication to scientific discovery and his collaborative efforts underscore the importance of teamwork in driving innovation forward. Geng's patents serve as a testament to his unwavering commitment to advancing biomedical science, making him a true trailblazer in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…